FDA’s Manufacturing Registration Rule’s Impact on Advanced Therapies: Part 1

Jul 24, 2026

Jason Bock, founder and CEO of CTMC, provides his perspective on the FDA’s proposed rule to streamline registration for single distributed manufacturing establishments, and what the change may mean for personalized medicines.

Listen to the full episode here: PharmTech

Bigger in Texas: Spilling the secrets on Houston’s biomanufacturing boom

Aug 29, 2026

An industry expert told us how recent projects in Houston speak to the city’s drive to become a premier biomanufacturing hub. Read the full article...

The Biggest Bottlenecks Holding Back Cell and Gene Therapy

Aug 24, 2026

Members of the 2026 Power List argue that manufacturing, infrastructure, reimbursement, and investment now pose the greatest challenges Read more...

FDA’s Manufacturing Registration Rule’s Impact on Advanced Therapies: Part 2

Jul 29, 2026

In part 2 of this 2-part interview, Jason Bock, founder and CEO of CTMC provides input on how the FDA's proposed manufacturing registration rule may...

Back

FDA’s Manufacturing Registration Rule’s Impact on Advanced Therapies: Part 1

Recent News

Bigger in Texas: Spilling the secrets on Houston’s biomanufacturing boom

The Biggest Bottlenecks Holding Back Cell and Gene Therapy

FDA’s Manufacturing Registration Rule’s Impact on Advanced Therapies: Part 2

Explore CTMC

Resources + Support

Contact Us